Product NDC: | 76237-289 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | lorazepam |
Active Ingredient(s): | .5 mg/1 & nbsp; lorazepam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76237-289 |
Labeler Name: | McKesson Contract Packaging |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077657 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120828 |
Package NDC: | 76237-289-39 |
Package Description: | 30 TABLET in 1 BLISTER PACK (76237-289-39) |
NDC Code | 76237-289-39 |
Proprietary Name | Lorazepam |
Package Description | 30 TABLET in 1 BLISTER PACK (76237-289-39) |
Product NDC | 76237-289 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lorazepam |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120828 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Contract Packaging |
Substance Name | LORAZEPAM |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |